Wednesday, July 8, 2026

Drug profile · INN

phentermine resin complex

phentermine resin complex (IONAMIN) is a norepinephrine transporter releasing agent. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — phentermine resin complex
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.89

Quick answer

phentermine resin complex (IONAMIN) is a norepinephrine transporter releasing agent. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN phentermine resin complex
Brand IONAMIN
Mechanism Norepinephrine transporter releasing agent
Target Sodium-dependent noradrenaline transporter
Route ORAL
Formulation CAPSULE, EXTENDED RELEASE

Mechanism of action

Norepinephrine transporter releasing agent

Primary target: Sodium-dependent noradrenaline transporter

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. amitriptyline hydrochloride Norepinephrine transporter inhibitor
  2. atomoxetine hydrochloride Norepinephrine transporter inhibitor
  3. desipramine hydrochloride Norepinephrine transporter inhibitor
  4. desvenlafaxine fumarate Norepinephrine transporter inhibitor
  5. doxepin hydrochloride Norepinephrine transporter inhibitor
  6. duloxetine hydrochloride Norepinephrine transporter inhibitor

Frequently asked questions

What is phentermine resin complex?

phentermine resin complex (IONAMIN) is a norepinephrine transporter releasing agent. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for phentermine resin complex?

IONAMIN is a marketed brand name for phentermine resin complex. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of phentermine resin complex?

phentermine resin complex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.